Comparing Nucala vs Trelegy Ellipta
| Nucala (mepolizumab) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|---|
| Nucala (mepolizumab) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Nucala is a biologic that works by blocking the action of IL-5 which is the main cytokine responsible for the survival and production of eosinophils. Nucala may be used to treat severe eosinophilic... View more |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
| More about Nucala (mepolizumab) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Nucala has an average rating of 7.3 out of 10 from a total of 99 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 16% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.8 out of 10 from a total of 259 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Nucala side effects |
View all Trelegy Ellipta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Nucala prices |
View all Trelegy Ellipta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
528 hours |
24 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 22 drugs are known to interact with Nucala:
|
A total of 539 drugs are known to interact with Trelegy Ellipta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
November 04, 2015 |
September 18, 2017 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.